Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-01 @ 1:07 PM
Study NCT ID:
NCT06373458
Status:
RECRUITING
Last Update Posted:
2025-09-30
First Post:
2024-04-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy
Sponsor:
Icahn School of Medicine at Mount Sinai
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY-23-01508
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |